# US 2015/0104503 A1 · Complexes and compositions containing curcumin

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0104503 A1
- Document ID: US20150104503A1
- Status: Published application
- Kind: A1
- Application number: 14/402,071
- Filed: 2013-05-22
- Published: 2015-04-16
- Earliest claimed: 2012-05-22
- Inventors: Harold Gordon Cave
- Web page: https://patentgrep.com/patent/US20150104503A1

## CPC

- A61K 31/4525: containing a five-membered ring with oxygen as a ring hetero atom
- A61K 31/12: Ketones
- A61K 31/202: having three or more double bonds, e.g. linolenic (eicosanoids, e.g. leukotrienes A61K31/557)
- A61K 31/352: condensed with carbocyclic rings, e.g. methantheline {(cannabinoids A61K31/658)}
- A61K 31/353: 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K 31/4453: only substituted in position 1, e.g. propipocaine, diperodon
- A61K 31/685: one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
- A61K 35/618: Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
- A61K 36/9066: Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 1/04: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 35/00: Antineoplastic agents
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A complex is provided, including a phospholipid and curcumin, wherein the phospholipid is sourced from a marine oil.

## Claims

### Claim 1

A complex comprising: a phospholipid and curcumin, wherein
some or all of the phospholipid is a marine oil phospholipid.

### Claim 2 (depends on 1)

The complex as claimed in claim 1 wherein the marine oil is mussel oil.

### Claim 3 (depends on 1)

The complex as claimed in claim 1 wherein the phospholipid includes DHA and/or EPA.

### Claim 4 (depends on 1)

The complex as claimed in claim 1 wherein at least a portion of the phospholipid in the complex is phosphatidylcholine.

### Claim 5 (depends on 1)

The complex as claimed in claim 1 wherein the complex includes between 1 to 15% w/w curcumin.

### Claim 6 (depends on 1)

The complex as claimed in claim 1 wherein the complex includes approximately 2-8% w/w curcumin.

### Claim 7 (depends on 1)

The complex as claimed in claim 1 wherein a molar ratio of the curcumin to polyunsaturated fatty acids in the complex is in the range of about 1:2 to 20:1.

### Claim 8 (depends on 1)

The complex as claimed in claim 1 wherein a molar ratio of the curcumin to polyunsaturated fatty acids in the complex is in the range of about 1:2 to 5:1.

### Claim 9 (depends on 1)

The complex as claimed in claim 1 wherein a ratio of curcumin to phospholipid in the complex is between 1:100 to 1:5.

### Claim 10 (depends on 1)

The complex as claimed in claim 1 wherein a ratio of curcumin to phospholipid in the complex is between 1:5 and 1:20.

### Claim 11 (depends on 1)

The complex as claimed in claim 1 wherein the marine oil contains greater than 20% w/w phospholipid.

### Claim 12 (depends on 1)

The complex as claimed in claim 1 wherein the marine oil contains approximately 40% w/w phospholipid.

### Claim 13 (depends on 1)

The complex as claimed in claim 1 wherein an amount of phospholipids in the complex are sourced from lecithin.

### Claim 14 (depends on 1)

The complex as claimed in claim 1 wherein the complex also includes piperine and/or quercetin.

### Claim 15 (depends on 1)

A composition including the complex as claimed in claim 1.

### Claim 16 (depends on 15)

The composition as claimed in claim 15 further including a marine oil.

### Claim 17 (depends on 15)

The composition as claimed in claim 15 wherein the composition includes lecithin.

### Claim 18 (depends on 17)

The composition as claimed in claim 17 wherein the ratio of lecithin to marine oil in the composition is between 1:3 to 3:1.

### Claim 19 (depends on 17)

The composition as claimed in claim 17 wherein the ratio of lecithin to marine oil in the composition is approximately 2:1.

### Claim 20 (depends on 17)

The composition as claimed in claim 17 wherein the lecithin is a vegetable oil.

### Claim 21 (depends on 15)

The composition as claimed in claim 15 wherein the composition includes a diluent.

### Claim 22 (depends on 21)

The composition as claimed in claim 21 wherein the ratio of diluent:lecithin:mussel oil is approximately 1:1:1.

### Claim 23 (depends on 21)

The composition as claimed in claim 21 wherein the diluent is oleic acid.

### Claim 24 (depends on 15)

The composition as claimed in claim 15 wherein the viscosity of the composition is below 5000 cPs when measured on a Spindle 21 at 35° C. at 1.5 rpm.

### Claim 25 (depends on 15)

The composition as claimed in claim 15 wherein the composition includes an added source of polyunsaturated fatty acids DHA and/or EPA.

### Claim 26 (depends on 15)

The composition as claimed in claim 15 wherein the composition includes an adjuvant.

### Claim 27 (depends on 15)

The composition as claimed in claim 15 wherein the composition includes quercetin.

### Claim 28 (depends on 15)

The composition as claimed in claim 15 wherein the composition includes piperine.

### Claim 29 (depends on 15)

The composition as claimed in claim 15 wherein the composition is provided in a liquid form in a soft gel capsule.

### Claim 30 (depends on 15)

The composition as claimed in claim 15 wherein the composition is provided in a solid dosage tablet form.

### Claim 31 (depends on 1)

A method of preparing a complex as claimed in claim 1, the method including the steps of:
a) dissolving a quantity of curcumin in a solvent to form a first solution;
b) mixing the first solution with a quantity of the phospholipid sourced from a marine oil to form a second solution;
c) processing the second solution to form the complex; and
d) separating the complex from the solvent.

### Claim 32 (depends on 31)

The method as claimed in claim 31 wherein the solvent is a Protic solvent.

### Claim 33 (depends on 31)

The method as claimed in claim 31 wherein solvent is ethanol.

### Claim 34 (depends on 31)

The method as claimed in claim 31 wherein step a) includes mixing approximately 40-50 parts volume of solvent to about 1 part curcumin.

### Claim 35 (depends on 31)

The method as claimed in claim 31 wherein step a) includes adding quercetin and/or piperine.

### Claim 36 (depends on 31)

The method as claimed in claim 31 wherein step b) includes addition of lecithin.

### Claim 37 (depends on 31)

The method as claimed in claim 31 wherein step b) includes addition of a diluent.

### Claim 38 (depends on 31)

The method as claimed in claim 31 wherein steps a), b) and/or c) include refluxing the solvent.

### Claim 39 (depends on 31)

The method as claimed in claim 31 wherein step c) includes applying a slow vacuum at around 40-50° C. for 1-2 hours and then a full vacuum until all the solvent is boiled off from the solution.

### Claim 40

(canceled)

### Claim 41

(canceled)
